Pfizer Inc financial data

Symbol
PFE on NYSE
Industry
Pharmaceutical Preparations
Location
66 Hudson Boulevard East, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 121 % -22.1%
Quick Ratio 26.2 % +7.65%
Debt-to-equity 140 % +29.6%
Return On Equity -2.83 % -113%
Return On Assets -1.18 % -111%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.67B shares +0.37%
Entity Public Float 207B USD -29.6%
Common Stock, Value, Issued 480M USD +0.42%
Weighted Average Number of Shares Outstanding, Basic 5.67B shares +0.35%
Weighted Average Number of Shares Outstanding, Diluted 5.7B shares -0.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 55.2B USD -29.7%
Revenue from Contract with Customer, Excluding Assessed Tax 91.8B USD +24.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.16B USD -118%
Income Tax Expense (Benefit) -1.6B USD -230%
Net Income (Loss) Attributable to Parent -2.6B USD -112%
Earnings Per Share, Basic -0.45 USD/shares -112%
Earnings Per Share, Diluted -0.45 USD/shares -112%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.05B USD -60%
Accounts Receivable, after Allowance for Credit Loss, Current 11.4B USD +11.4%
Inventory, Net 11.4B USD +11%
Other Assets, Current 4.19B USD -13.2%
Assets, Current 37.8B USD -48.4%
Other Long-term Investments 3.12B USD -14.4%
Property, Plant and Equipment, Net 19B USD +8.4%
Operating Lease, Right-of-Use Asset 2.92B USD -2.6%
Intangible Assets, Net (Excluding Goodwill) 61.2B USD +47.9%
Goodwill 68.4B USD +32.7%
Other Assets, Noncurrent 10.7B USD -17.8%
Assets 216B USD -1.81%
Accounts Payable, Current 5.11B USD -16%
Employee-related Liabilities, Current 2.57B USD +30.1%
Contract with Customer, Liability, Current 2.53B USD +96.6%
Liabilities, Current 43.8B USD +26.5%
Deferred Income Tax Liabilities, Net 2.23B USD +80.8%
Operating Lease, Liability, Noncurrent 2.63B USD +1.12%
Other Liabilities, Noncurrent 16.1B USD +20.1%
Liabilities 128B USD +6.08%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.82B USD +3.53%
Retained Earnings (Accumulated Deficit) 117B USD -9.47%
Stockholders' Equity Attributable to Parent 87.7B USD -11.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 88B USD -11.4%
Liabilities and Equity 216B USD -1.81%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.09B USD -10.1%
Net Cash Provided by (Used in) Financing Activities -4.93B USD -78%
Net Cash Provided by (Used in) Investing Activities 1.73B USD -47.8%
Common Stock, Shares Authorized 12B shares 0%
Common Stock, Shares, Issued 9.56B shares +0.45%
Common Stock, Par or Stated Value Per Share 0.05 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.14B USD -222%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.12B USD -58.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 415M USD -0.96%
Deferred Tax Assets, Valuation Allowance 1.74B USD +12.8%
Deferred Tax Assets, Gross 19B USD +28.6%
Operating Lease, Liability 3.15B USD -1.99%
Payments to Acquire Property, Plant, and Equipment 704M USD -38.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.31B USD -111%
Lessee, Operating Lease, Liability, to be Paid 3.82B USD -0.52%
Property, Plant and Equipment, Gross 35B USD +11.2%
Operating Lease, Liability, Current 527M USD -15%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +33.3%
Deferred Income Tax Expense (Benefit) -441M USD +26.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 671M USD +7.02%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 27M shares 0%
Unrecognized Tax Benefits 4.8B USD +6.85%
Additional Paid in Capital 93.2B USD +0.94%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.3B USD
Depreciation, Depletion and Amortization 1.74B USD +16.7%
Deferred Tax Assets, Net of Valuation Allowance 17.3B USD +30.4%
Interest Expense 2.95B USD +104%